These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8879993)

  • 1. Molecular genetic basis of the human chondrodysplasias.
    Horton WA
    Endocrinol Metab Clin North Am; 1996 Sep; 25(3):683-97. PubMed ID: 8879993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of the human chondrodysplasias-1995.
    Horton WA
    Eur J Hum Genet; 1995; 3(6):357-73. PubMed ID: 8825578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The genetic basis of the osteochondrodysplasias.
    Baitner AC; Maurer SG; Gruen MB; Di Cesare PE
    J Pediatr Orthop; 2000; 20(5):594-605. PubMed ID: 11008738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in human chondrodysplasias: molecular genetics.
    Horton WA
    Ann N Y Acad Sci; 1996 Jun; 785():150-9. PubMed ID: 8702121
    [No Abstract]   [Full Text] [Related]  

  • 5. Some chondrodysplasias with short limbs: molecular perspectives.
    Cohen MM
    Am J Med Genet; 2002 Oct; 112(3):304-13. PubMed ID: 12357475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia.
    Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
    Acta Paediatr Suppl; 1996 Oct; 417():33-8. PubMed ID: 9055906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism.
    Bonaventure J; Rousseau F; Legeai-Mallet L; Le Merrer M; Munnich A; Maroteaux P
    Am J Med Genet; 1996 May; 63(1):148-54. PubMed ID: 8723101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia].
    Rousseau F; Bonaventure J; Le Merrer M; Maroteaux P; Munnich A
    Ann Endocrinol (Paris); 1996; 57(3):153. PubMed ID: 8949408
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and segregation analysis of the type II collagen gene (COL2A1) in some heritable chondrodysplasias.
    Wordsworth P; Ogilvie D; Priestley L; Smith R; Wynne-Davies R; Sykes B
    J Med Genet; 1988 Aug; 25(8):521-7. PubMed ID: 2902229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level.
    Cohen MM
    Int J Oral Maxillofac Surg; 1998 Dec; 27(6):451-5. PubMed ID: 9869286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormality of type IX collagen in a patient with diastrophic dysplasia.
    Diab M; Wu JJ; Shapiro F; Eyre D
    Am J Med Genet; 1994 Feb; 49(4):402-9. PubMed ID: 8160734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor 3 and the human chondrodysplasias.
    Horton WA
    Curr Opin Pediatr; 1997 Aug; 9(4):437-42. PubMed ID: 9300204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gly380Arg and Asn540Lys mutations of fibroblast growth factor receptor 3 in achondroplasia and hypochndroplasia in the Spanish population].
    Ezquieta Zubicaray B; Iguacel AO; Varela Junquera JM; Jariego Fente CM; González Gancedo P; Gracia Bouthelier R
    Med Clin (Barc); 1999 Mar; 112(8):290-3. PubMed ID: 10207844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular defects in the chondrodysplasias.
    Rimoin DL
    Am J Med Genet; 1996 May; 63(1):106-10. PubMed ID: 8723095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia.
    Bellus GA; McIntosh I; Smith EA; Aylsworth AS; Kaitila I; Horton WA; Greenhaw GA; Hecht JT; Francomano CA
    Nat Genet; 1995 Jul; 10(3):357-9. PubMed ID: 7670477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular diagnosis of the skeletal dysplasias associated with mutations in the gene encoding Fibroblast Growth Factor Receptor 3 (FGFR3) in Portugal.
    Almeida MR; Campos-Xavier AB; Medeira A; Cordeiro I; Sousa AB; Lima M; Soares G; Rocha M; Saraiva J; Ramos L; Sousa S; Marcelino JP; Correia A; Santos HG
    Clin Genet; 2009 Feb; 75(2):150-6. PubMed ID: 19215249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in molecular analysis of skeletal dysplasia.
    Ozono K
    Acta Paediatr Jpn; 1997 Aug; 39(4):491-8. PubMed ID: 9316299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutations in the Fibroblast Growth Factor Receptor 3 gene (FGFR3) in Chilean patients with idiopathic short stature, hypochondroplasia and achondroplasia].
    Mancilla EE; Poggi H; Repetto G; García C; Foradori A; Cattani A
    Rev Med Chil; 2003 Dec; 131(12):1405-10. PubMed ID: 15022403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita.
    Unger S; Korkko J; Krakow D; Lachman RS; Rimoin DL; Cohn DH
    Am J Med Genet; 2001 Nov; 104(2):140-6. PubMed ID: 11746045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of parathyroid hormone-related peptide and its receptors.
    Martin TJ
    N Engl J Med; 1996 Sep; 335(10):736-8. PubMed ID: 8703176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.